Topic:

Infectious Diseases

Latest Headlines

Latest Headlines

Merck's Gardasil earns high safety marks

Merck's ($MRK) Gardasil, the human papillomavirus vaccine to prevent cervical cancer, garnered high safety marks in the second large-scale study of side effects in the past year.

Atreca lands $6M for vaccine research

Atreca, a San Carlos, CA-based biopharmaceutical company, captured a $6 million investment from the Bill & Melinda Gates Foundation to accelerate the discovery and development of novel vaccines and therapeutics for human infectious diseases.

Cardiff University works on anthrax vaccine for NATO

Scientists from the U.K.'s Cardiff University are leading a NATO project to develop an anthrax vaccine.

Emory snags $6M for HIV/AIDS vaccine research

Researchers at Emory University landed a $6 million grant from the Bill & Melinda Gates Foundation to help develop an effective vaccine for HIV/AIDS.

Intercell's Jeev vaccine debuts in India

After launching its Japanese encephalitis vaccine in India, Austrian biotech group Intercell aims to win approval for other Asian countries.

Whooping cough vaccine needs booster, scientists say

With about 26,000 new cases of pertussis recorded so far this year, 2012 has marked the largest outbreak of the disease in the past 50 years, and scientists say more research is needed to find a better vaccine.

Sanofi's dengue vaccine falters in clinical trial

Lackluster results from a recent clinical trial has cast doubts on Sanofi's dengue fever vaccine, not to mention the Big Pharma's future sales expectations.

Public sector picks up drug and vaccine development again

In a post-9/11 world, fears over pandemics and bioterrorism have renewed drug and vaccine development in the public sector, as national governments funnel research toward combating infectious diseases, like anthrax.

University of Oklahoma advances work on West Nile vaccine

In Oklahoma, one of the states hit worst by the West Nile virus this year, researchers at the University of Oklahoma Health Sciences Center are working on a vaccine, and the findings have been promising so far.

Herd immunity halts cholera in unvaccinated population in Zanzibar, study shows

On the Tanzanian island of Zanzibar, some individuals may not even need a vaccine to protect them against cholera. Research shows herd immunity has helped guard against the disease in sub-Saharan Africa.